Roche Diagnostics is a global in vitro diagnostics leader and a core division of the Roche Group, focused on solutions for early detection, prevention, diagnosis, treatment monitoring, and health management. Its portfolio spans central laboratory systems, molecular diagnostics, near-patient testing, tissue diagnostics, diabetes care, and laboratory automation and digital connectivity, with major platforms built around the cobas®, VENTANA®, Accu-Chek®, CoaguChek®, and navify® ecosystems.

■ Product Portfolio

Vicbio Biotechnology Co., Ltd. provides the full range of Roche Diagnostics products.

⇨ Inquire or Order immediately ⇦

●Central Laboratory and Protein Diagnostic Solutions

Roche provides high-throughput, highly automated solutions for hospital core laboratories. The cobas® pro integrated solutions are designed to connect multiple analytical modules in a streamlined workflow, while the cobas® c and cobas® e platforms support a broad routine and specialty menu across clinical chemistry and immunoassay testing. These systems are used for applications such as liver and kidney function, lipids, cardiac markers, tumor markers, infectious diseases, hormones, and coagulation-related testing. 

●Molecular Diagnostic Solutions

Roche’s molecular diagnostics portfolio is focused on nucleic acid testing at the genetic level. The cobas® 6800/8800 systems provide automated, integrated PCR-based workflows for high-throughput molecular testing and are widely used in infectious disease screening and monitoring. The cobas® Liat® system offers rapid molecular testing in a compact format, while the AVENIO portfolio supports next-generation sequencing applications in oncology, including tissue- and blood-based analysis for precision medicine. Typical application areas include viral load testing, blood screening, HPV testing, tumor mutation analysis, and pharmacogenomics. 

●Near-Patient Care Solutions

Roche also offers near-patient and point-of-care solutions designed to deliver rapid results closer to the patient. These include the cobas® Liat® molecular platform, the Accu-Chek® diabetes management portfolio, the CoaguChek® coagulation monitoring range for INR testing, and blood gas systems such as the cobas® b 123 platform for critical care settings. Together, these products support faster clinical decision-making in decentralized care environments. 

●Tissue Diagnostic Solutions

Roche’s tissue diagnostics portfolio is centered on cancer pathology and includes sample preparation, staining, analysis, and workflow solutions. The VENTANA® product family covers automated tissue staining systems, special stains, immunohistochemistry platforms, and companion diagnostic assays. Roche also supports precision oncology through assays such as PD-L1 testing, helping identify patients who may benefit from targeted or immuno-oncology therapies. 

●Diabetes Management Solutions

The Accu-Chek® brand provides Roche’s diabetes care solutions, including blood glucose monitoring systems and related digital management tools. This portfolio is designed to support ongoing glucose monitoring, patient self-management, and integrated diabetes care workflows. 

●Laboratory Automation and IT Solutions

Roche also provides laboratory automation and digital connectivity solutions for sample handling, workflow optimization, and data management. Its portfolio includes cobas® pre-analytical systems and navify® / cobas® IT solutions that connect instruments, middleware, and laboratory information systems to support efficient end-to-end laboratory operations. 

■ Product List